At Fresenius Medical Care, according to a recent post on the FCPA Blog, management owned the graft and senior executives directed the bribery and the global cover up. The failures were both wide and deep, where “legal, compliance, and internal audit functions failed to detect and prevent the bribery,” the company said in an SEC filing.… Continue Reading
The SEC summed up the criminal activity in the corner offices this way: In many instances, senior management actively thwarted compliance efforts, personally engaging in corruption schemes and directing employees to destroy records of the misconduct.… Continue Reading
The world’s biggest provider of dialysis equipment and services agreed Friday to pay the DOJ and SEC $231 million in penalties and disgorgement to resolve violations of the Foreign Corrupt Practices Act across Africa, the Middle East, and Europe.… Continue Reading
Fresenius Medical Care AG said in a securities filing Tuesday that it has set aside €200 million ($245 million) for a potential FCPA resolution with the DOJ and SEC.
Fresenius, based in Homburg, Germany, said the money “represents an estimate from a range of potential outcomes.”… Continue Reading